Insider Trading History of Hoffman Michael B

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Hoffman Michael B since 2018. This trader's CIK number is 1290208. At the time of last reporting, Hoffman Michael B was the Officer of Annovis Bio, Inc.. (stock ticker symbol ANVS). Also see all insider trading activities at Annovis Bio, Inc..

Note that in the past Hoffman Michael B also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Traws Pharma, Inc. (ONTX) by Hoffman Michael B

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 ONTX 0 $0 184,368 $50,148 0 $0
2018 ONTX 2,211,765 $0 99,999 $45,159 0 $0

Yearly summary of insider trading at Annovis Bio, Inc. (ANVS) by Hoffman Michael B

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ANVS 975,610 $2,000,000 0 $0 0 $0
2022 ANVS 0 $0 0 $0 37,142 $86,169
2020 ANVS 33,333 $199,998 0 $0 0 $0


Insider trading activities at 2 companies by Hoffman Michael B:

1. Traws Pharma, Inc. (ONTX)

2. Annovis Bio, Inc. (ANVS)

Table 1. Insider trading of Traws Pharma, Inc. (ONTX) by Hoffman Michael B

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-08-27 ONTX Sale 184,368 .27 50,148
2018-08-28 ONTX Sale 50,000 .45 22,550
2018-08-27 ONTX Sale 20,000 .45 9,080
2018-08-29 ONTX Sale 29,999 .45 13,529
2018-04-27 ONTX Buy 2,211,765 .00 0

Table 2. Insider trading of Annovis Bio, Inc. (ANVS) by Hoffman Michael B

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-10-28 ANVS Buy 975,610 2.05 2,000,000
2022-01-04 ANVS Option Ex 37,142 2.32 86,169
2020-01-31 ANVS Buy 33,333 6.00 199,998

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hoffman Michael B (Officer of Annovis Bio, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.